UNSPSC 85877157: Fluoroscopy of pelvis using low osmolar contrast

This classification denotes the group of activities that yields a imaging intervention or procedure to fluoroscopy of pelvis using low osmolar contrast. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code BR1C1ZZ

UNSPSC 85877157 Fluoroscopy of pelvis using low osmolar contrast is a Commodity code that nominally describes a specific diagnostic imaging procedure, but recent state and local activity under this code shows little alignment with that narrow clinical scope. The three recent opportunities tagged to this code span diagnostic imaging systems infrastructure (a PACS implementation), ultrasound equipment procurement, and phlebotomy services—none of which are fluoroscopy procedures using low osmolar contrast. The mismatch suggests either classification error in how these opportunities were tagged or a broader administrative categorization that does not reflect the code's stated clinical definition. State and local government procurement under codes in this space typically involves hospital systems, county health departments, and public medical centers seeking imaging technology, equipment, and diagnostic support services, but the recent record for this specific code does not support sustained or focused activity in fluoroscopy-related purchasing.

Geographic activity is scattered across three states with no pattern of repeat buyers: San Mateo County, California (San Mateo Medical Center's PACS solicitation, RFP due August 7, 2026), Collier County, Florida (single-source ultrasound equipment notice, March 2026), and Bernalillo County and City of Albuquerque, New Mexico (phlebotomy services RFB, due February 25, 2026). No recent opportunities specifically solicit fluoroscopy equipment, contrast agents, or fluoroscopy-related professional services. The code shows little relevant current activity worth pursuing; vendors focused on fluoroscopy systems or contrast media should monitor higher-tier imaging codes or audit how their offerings are being classified in state and local procurement systems.